ROTH Capital Partners Acts as Joint Book-Running Manager
for Apollo Endosurgery, Inc. (NASDAQ: APEN)
in its $36 Million Follow-On

For more information please contact:

Investment Banking
Eric B. Cheng
Managing Director
Co-Head of Healthcare Investment Banking
(646) 358-1901

echeng@roth.com

 

James Antonopoulos
Managing Director
Co-Head of Healthcare Investment Banking
(646) 358-1906

jantonopoulos@roth.com

 

Equity Capital Markets
Aaron Gurewitz
Head of Equity
Capital Markets
(949) 720-5703

agurewitz@roth.com

 

Nazan Akdeniz
Senior Vice President
(949) 720-5740

nakdeniz@roth.com

 

Lou Ellis
Senior Vice President
(949) 720-5739

lellis@roth.com

Transaction Information

Apollo Endosurgery, Inc. (NASDAQ: APEN), a medical technology company primarily focused on the design, development and commercialization of innovative medical devices that can be used for the treatment of obesity, has completed an underwritten public offering of 6,542,453 shares of its common stock, which includes the sales of 853,363 additional shares pursuant to the full exercise of the over-allotment option granted to the underwriters. The shares were sold at the public offering price of $5.50 per share, resulting in the gross proceeds for Apollo Endosurgery, Inc. of approximately $36 Million.

  

ROTH Capital Partners acted as joint book-running manager for the offering.

 

About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Apollo’s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 80 countries today. For more information, please visit http://apolloendo.com. (Source: Company Press Release | 7/20/17)

 

About ROTH Capital Partners

ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S.  For more information on ROTH, please visit www.roth.com.

About ROTH Investment Banking Private Capital Institutional Sales & Trading
Research Corporate Services Marketing & Conferences Press Room

The material, information and  facts discussed in this announcement other than the information regarding ROTH Capital Partners, LLC ("ROTH") and its affiliates, are from sources believed to be reliable, but are in no way guaranteed to be complete or accurate. This announcement should not be used as a complete analysis of any companies, securities or topics discussed herein. Additional information is available upon request. This is not, however, an offer or solicitation of the securities discussed. Any opinions or estimates in this announcement are subject to change without notice. An investment in any security based on this announcement may involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Additionally, such investments may involve a high degree of risk and may not be suitable for all investors. No part of this announcement may be reproduced in any form without the express written permission of ROTH. Copyright 2017.